University Hospital Tuebingen

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

163

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

10 drugs in development

Phase 22

Phase 15

Preclinical3

By Therapeutic Area

top 2

Oncology

440%

Respiratory

110%

R&D Momentum

66/100

Pipeline Velocity

32/100

Trial Completion Rate

72/100

Pipeline Concentration

42/100

Pipeline Freshness

29/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Respiratory but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 24, 2026

Recruiting

A Randomized, Double-blind, Placebo-controlled, 104-week Proof-of-concept Study to Evaluate the Efficacy of Intravenous Prasinezumab in Participants With Parkinson's Disease Carrying a Severe Mutation in the GBA Gene

Oct 22, 2026

Recruiting

Digital Cognitive Assessment in Stroke Patients for Evaluating Long-Term Cognitive Recovery: The TuCAN App for Patients With Middle Cerebral Artery Ischemia (TuCAN-Media)"

Earlier

Oct 14, 2026TrialBlood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

Oct 14, 2026TrialRadiochemotherapy With Concomitant Deep Regional Hyperthermia in Locally Advanced Rectal Cancer. A Prospective, Randomized Phase III Trial.

Oct 7, 2026TrialRandomized Phase II Study of Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Biochemical Relapse of Prostate Cancer

Oct 2, 2026TrialEvaluation of Low-thermal Argon Plasma Devitalization (LtAPD) for the Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade 2 Versus Standard of Active Surveillance

Oct 1, 2026TrialRobot-assisted vs. Open Inguinal Lymphadenectomy for Penile Cancer - a Prospective Randomized Trial With a Supporting Translational Program

Sep 30, 2026TrialA Phase IIb, Open-label, Multicenter Study of Radiochemotherapy With Isotoxic Dose Escalation and Protective VEGF Inhibition Using Bevacizumab in the Treatment of Patients With First Diagnosis of IDH Wild-type, MGMT Unmethylated Glioblastoma

4 more events

Sep 16, 2026TrialSGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes - a Randomized, Placebo Controlled, Multi-center Trial

Sep 15, 2026TrialFusionVAC22_02: DNAJB1-PRKACA Fusion Transcript-based Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Oncogenic Driver Fusion

Sep 10, 2026TrialTranscutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion in Patients With Long/Post-COVID.

Sep 3, 2026TrialNon-Interventional Study on the Prevalence of Cardiac Amyloidosis in Patients With Higher-Grade Aortic Valve Stenosis - Evaluation Using Echocardiography, Computed Tomography, Tc99-SPECT/CT and Cardiac Magnetic Resonance Imaging (CMR)